Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
CC transcript
Asset disposition
Acq. announced
Director departure
Appointed director
|
|
MEDICINES CO (MDCO)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 12/10/2019 |
GN
| SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates Whether The Sale Of These Companies Is Fair To Shareholders – MDCO, TIF, AMTD, CARO |
| 12/04/2019 |
GN
| INVESTIGATION ALERT: Halper Sadeh LLP Investigates Whether The Sale Of These Companies Is Fair To Shareholders – AMTD, TIF, MDCO, PGNX |
| 12/03/2019 |
GN
| MDCO, IPHS, BREW, and CARB SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Buyouts |
| 11/25/2019 |
GN
| SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Regarding Whether the Sale of The Medicines Company to Novartis AG is Fair to Shareholders |
| 11/25/2019 |
GN
| Shareholder Investigation Alert: Halper Sadeh LLP Investigates Whether the Sale of These Companies is Fair to Shareholders – MDCO, AMTD, TIF, BREW |
| 11/05/2018 |
GN
| Report: Exploring Fundamental Drivers Behind SkyWest, Blueprint Medicines, HP, Hewlett Packard Enterprise, Cardinal Health, and The Medicines — New Horizons, Emerging Trends, and Upcoming Developments |
| 08/14/2018 |
GN
| Report: Exploring Fundamental Drivers Behind EnLink Midstream, CENTENNIAL RES, Mondelez International, Pacific Premier, Farmland Partners, and The Medicines — New Horizons, Emerging Trends, and Upcoming Developments |
| 04/25/2018 |
BW
| The Medicines Company Reports First-Quarter 2018 Results |
| 04/19/2018 |
BW
| The Medicines Company to Announce First-Quarter 2018 Financial Results on April 25 |
| 03/16/2018 |
BW
| The Medicines Company to Participate in the Oppenheimer 28th Annual Healthcare Conference |
| 02/21/2018 |
BW
| The Medicines Company Reports Fourth-Quarter and Full-Year 2017 Business and Financial Results |
| 02/15/2018 |
GN
| Investor Expectations to Drive Momentum within Workday, The Medicines, Celldex Therapeutics, Lannett, Oclaro, and Antares Pharma — Discovering Underlying Factors of Influence |
| 02/14/2018 |
BW
| The Medicines Company to Host Conference Call and Webcast Discussing Fourth-Quarter and Full-Year 2017 Financial Results |
| 01/08/2018 |
GN
| Melinta Therapeutics Completes Acquisition of The Medicines Company's Infectious Disease Portfolio |
| 12/13/2017 |
BW
| The Medicines Company to Host Investor Day on January 23, 2018 |
| 12/01/2017 |
GN
| Report: Exploring Fundamental Drivers Behind Lannett, Oclaro, Antares Pharma, Workday, The Medicines, and Celldex Therapeutics — New Horizons, Emerging Trends, and Upcoming Developments |
| 11/29/2017 |
GN
| Melinta Therapeutics Enters Into Agreement to Acquire Infectious Disease Business from The Medicines Company |
|
|